Business

Delivra Health Brands Reports Continued Revenue Growth and Positive Adjusted EBITDA(1) in FY2025

Dream Water® USA and Dream Water® Canada achieve double digit revenue growth in e-comme...

articleDelivra Health Brands IncOctober 6, 20254/company/delivra-health-brands-inc/news/delivra-health-brands-reports-continued-revenue-growth-and-positive-adjusted-ebitda1-in-fy2025
Delivra Health Brands Reports Continued Revenue Growth and Positive Adjusted EBITDA(1) in FY2025

About this update from Delivra Health Brands Inc

[{"type":"text","content":"Delivra Health Brands Reports Continued Revenue Growth and Positive Adjusted EBITDA(1) in FY2025Dream Water® USA and Dream Water® Canada achieve double digit revenue growth in e-commerce and retail channelsLivRelief™ Canada achieves double-digit revenue growth in ecommerceStrong Dream Water and LivRelief results partially offset by reduced revenues in LivRelief Infused business. Management implementing new route-to-market strategy to recapture growthContinued overall net revenue growth of 8% year over yearIncreased year over year gross profit in fiscal 2025 vs. fiscal 2024Vancouver, British Columbia--(Newsfile Corp. - October 6, 2025) - Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF) (\"Delivra Health\" or the \"Company\"), a consumer packaged goods company uniquely positioned in the health and wellness sector, is pleased to announce its financial and operating results for the 12 months ended June 30, 2025 (\"fiscal 2025\"). The Delivra Health portfolio features innovative brands Dream Water® and LivRelief™, which deliver relief from common health issues such as sleeplessness, chronic pain and anxiety.Management Commentary\"Delivra Health Brands is pleased to report double-digit revenue growth for Dream Water® USA and Dream Water® Canada in our e-commerce and retail channels,\" said Gord Davey, President and CEO of the Company. \"LivRelief™ also finished the year with double-digit growth in our e-commerce channel. These results highlight the growing strength of our brands and the effectiveness of our marketing investments. These strong results were partially offset by a reduction in revenue in our licensed LivRelief™ Infused business, however, we are revising its route-to-market strategy to capitalize on strong consumer demand in both the medical and recreational segments.\" Mr. Davey continued, \"Looking forward, strong traction with major retail customers, opportunities for global expansion, and a pipeline of innovative of new products give us confidence that we can achieve significantly improved top line and bottom-line results for the Company in the coming year. Our commitment remains clear — delivering breakthrough solutions for consumers while creating sustainable, long-term value for our shareholders.\" Financial Highlights Net revenue: The Compan...

More updates from Delivra Health Brands Inc